Indirect genomic effects on survival from gene expression data

Genome Biology

Volumn 9, Issue 3, 2008, Pages

  Ferkingstad, Egil ^a,b   Frigessi, Arnoldo ^a   Lyng, Heidi ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CANCER GENETICS; CANCER SURVIVAL; DATA ANALYSIS; GENE EXPRESSION; GENE INTERACTION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; METHODOLOGY; MICROARRAY ANALYSIS; QUANTITATIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL MODEL; TUMOR GROWTH; BIOLOGY; DNA MICROARRAY; FEMALE; GENETICS; GENOMICS; MALE; MORTALITY; NEOPLASM; REGRESSION ANALYSIS;

COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION; GENOMICS; HUMANS; MALE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REGRESSION ANALYSIS; TRANSCRIPTION FACTORS;

EID: 45549094777     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2008-9-3-r58     Document Type: Article

References (47)

1. Bair E Tibshirani R Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2004, 2;E108. 387275 15094809 10.1371/journal.pbio.0020108
2. Bullinger L Döhner K Bair E Fröhling S Schlenk RF Tibshirani R Döhner H Pollack JR Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004, 350:1605-1616. 10.1056/NEJMoa031046 15084693
3. Hastie T Tibshirani R Botstein D Brown P Supervised harvesting of expression trees. Genome Biol 2001, 2. research0003.1 0003.12 10.1186/ gb-2001-2-1-research0003
4. Schumacher M Binder H Gerds T Assessment of survival prediction models based on microarray data. Bioinformatics 2007, 23:1768-1774. 10.1093/ bioinformatics/btm232 17485430
5. Bøvelstad H Nygård S Størvold H Aldrin M Borgan Ø Frigessi A Lingjærde OC Predicting survival from microarray data - a comparative study. Bioinformatics 2007, 23:2080-2087. 10.1093/bioinformatics/btm305 17553857
6. Margolin AA Nemenman I Basso K Wiggins C Stolovitzky G Dalla F Califano A ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006, 7(Suppl 1):S7. 1810318 16723010 10.1186/1471-2105-7-S1-S7
7. Tuck DP Kluger HM Kluger Y Characterizing disease states from topological properties of transcriptional regulatory networks. BMC Bioinformatics 2006, 7:236. 1482723 16670008 10.1186/1471-2105-7-236
8. Nikitin A Egorov S Daraselia N Mazo I Pathway studio - the analysis and navigation of molecular networks. Bioinformatics 2003, 19:2155-2157. 10.1093/bioinformatics/btg290 14594725
9. Chang WC Li CW Chen BS Quantitative inference of dynamic regulatory pathways via microarray data. BMC Bioinformatics 2005, 6;44. 555938 15748298 10.1186/1471-2105-6-44
10. Tringe SG Wagner A Ruby SW Enriching for direct regulatory targets in perturbed gene-expression profiles. Genome Biol 2004, 5:R29. 395788 15059262 10.1186/gb-2004-5-4-r29
11. Anderson JE Hansen LL Mooren FC Post M Hug H Zuse A Los M Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine. Drug Resist Updat 2006, 9:198-210. 10.1016/j.drup.2006.08.001 17011811
12. He YD Genomic approach to biomarker identification and its recent applications. Cancer Biomark 2006, 2:103-133. 17192065
13. Macgregor PF Gene expression in cancer: The application of microarrays. Expert Rev Mol Diagn 2003, 3;185-200. 10.1586/14737159.3.2.185 12647995
14. Shai RM Microarray tools for deciphering complex diseases. Front Biosci 2006, 11:1414-1424. 10.2741/1892 16368525
15. Slee E O'Connor D Lu X To die or not to die: How does p53 decide? Oncogene 2004, 23:2809-2818. 10.1038/sj.onc.1207516 15077144
16. Matsumura I Tanaka H Kanakura Y E2F1 and c-Myc in cell growth and death. Cell Cycle 2003, 2:333-338. 12851485
17. Kim R Tanabe K Emi M Uchida Y Inoue H Toge T Inducing cancer cell death by targeting transcription factors. Anticancer Drugs 2003, 14:3-11. 10.1097/00001813-200301000-00002 12544253
18. Basso K Margolin AA Stolovitzky G Klein U Dalla-Favera R Califano A Reverse engineering of regulatory networks in human B cells. Nat Genet 2005, 37;382-390. 10.1038/ng1532 15778709
19. Aalen OO A linear regression model for the analysis of life times. Stat Med 1989, 8:907-925. 10.1002/sim.4780080803 2678347
20. Fosen J Ferkingstad E Borgan Ø Aalen OO Dynamic path analysis - a new approach to analyzing time-dependent covariates. Lifetime Data Anal 2006, 12;143-167. 10.1007/s10985-006-9004-2 16817006
21. van de Vijver MJ He YD van't Veer LJ Dai H Hart AAM Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ Parrish M Atsma D Witteveen A Glas A Delahaye L van der Velde T Bartelink H Rodenhuis S Rutgers ET Friend SH Bernards R A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967 12490681
22. van Houwelingen HC Bruinsma T Hart AA van't Veer LJ Wessels LF Cross-validated Cox regression on microarray gene expression data. Stat Med 2006, 25:3201-3216. 10.1002/sim.2353 16143967
23. Miller LD Smeds J George J Vega VB Vergara L Ploner A Pawitan Y Hall P Klaar S Liu ET Bergh J An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005, 102:13550-13555. 1197273 16141321 10.1073/pnas.0506230102
24. Rosenwald A Wright G Chan WC Connors JM Campo E Fisher RI Gascoyne RD Muller-Hermelink HK Smeland EB Giltnane JM Hurt EM Zhao H Averett L Yang L Wilson WH Jaffe ES Simon R Klausner RD Powell J Duffey PL Longo DL Greiner TC Weisenburger DD Sanger WG Dave BJ Lynch JC Vose J Armitage JO Montserrat E López-Guillermo A The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947. 10.1056/NEJMoa012914 12075054
25. Ahmed W Ziouzenkova O Brown J Devchand P Francis S Kadakia M Kanda T Orasanu G Sharlach M Zandbergen F Plutzky J PPARs and their metabolic modulation: New mechanisms for transcriptional regulation? J Intern Med 2007, 262:184-198. 10.1111/j.1365-2796.2007.01825.x 17645586
26. DeGregori J Johnson DG Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006, 6:739-748. 17100600
27. Buitenhuis M Coffer PJ Koenderman L Signal transducer and activator of transcription 5 (STAT5). Int J Biochem Cell Biol 2004, 36:2120-2124. 10.1016/j.biocel.2003.11.008 15313458
28. Oster SK Ho CS Soucie EL Penn LZ The myc oncogene: MarvelouslY complex. Adv Cancer Res 2002, 84:81-154. 11885563
29. Whiteman HJ Farrell PJ RUNX expression and function in human B cells. Crit Rev Eukaryot Gene Expr 2006, 16;31-44. 16584381
30. Kiec-Wilk B Dembinska-Kiec A Olszanecka A Bodzioch M Kawecka-Jaszcz K The selected pathophysiological aspects of PPARs activation. J Physiol Pharmacol 2005, 56:149-162. 15985699
31. Targett-Adams P McElwee MJ Ehrenborg E Gustafsson MC Palmer CN McLauchlan J A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta 2005, 1728:95-104. 15777674
32. Tu AY Albers JJ Glucose regulates the transcription of human genes relevant to HDL metabolism: Responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes 2001, 50:1851-1856. 10.2337/ diabetes.50.8.1851 11473048
33. Ge H Cha JY Gopal H Harp C Yu X Repa JJ Li C Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 2005, 46:1484-1490. 10.1194/jlr.M500005-JLR200 15863837
34. Claassen GF Hann SR Myc-mediated transformation: The repression connection. Oncogene 1999, 18;2925-2933. 10.1038/sj.onc.1202747 10378689
35. Durst KL Hiebert SW Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 2004, 23:4220-4224. 10.1038/ sj.onc.1207122 15156176
36. Jarrar MH Baranova A PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: The importance of interplay with TGFbeta signalling. J Cell Mol Med 2007, 11;71-87. 10.1111/ j.1582-4934.2007.00003.x 17367502
37. Fenner MH Elstner E Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer. Expert Opin Investig Drugs 2005, 14;557-568. 10.1517/13543784.14.6.557 16004588
38. Humphreys RC Hennighausen L Transforming growth factor alpha and mouse models of human breast cancer. Oncogene 2000, 19:1085-1091. 10.1038/ sj.onc.1203278 10713694
39. Pützer BM E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 2007, 11:239-251. 10.1111/j.1582-4934.2007.00030.x 17488475
40. Ponzielli R Katz S Barsyte-Lovejoy D Penn LZ Cancer therapeutics: targeting the dark side of Myc. Eur J Cancer 2005, 41:2485-2501. 10.1016/ j.ejca.2005.08.017 16243519
41. Lauritzen S Graphical Models Oxford: Clarendon Press 1996.
42. Aalen OO A model for non-parametric regression analysis of counting processes. Lecture Notes Statistics 1980, 2:1-25.
43. Cox DR Regression models and life-tables. J R Stat Soc [Ser B] 1972, 34:187-220.
44. Efron B Censored data and the bootstrap. J Am Stat Assoc 1981, 76:312-319. 10.2307/2287832
45. R Development Core Team R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing 2007
46. R Package addreg for Additive Hazard Regression Analysis http://www.med.uio.no/imb/stat/addreg
47. R package for indirect genomic effects on survival http://www.nr.no/ ~egil/indirect/